Use of mode of action in risk assessment: Past, present, and future

被引:25
作者
Clewell, H [1 ]
机构
[1] ENVIRON Hlth Sci Inst, Ruston, LA 71270 USA
关键词
mode of action; risk assessment; methodology; trichloroethylene; arsenic;
D O I
10.1016/j.yrtph.2005.01.008
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The evolution of chemical risk assessment has been marked by a steadily increasing expectation for the use of chemical-specific dosimetric and mechanistic information to tailor the risk assessment approach. The information to be used can range from the broad physical properties of the chemical to detailed information on the mechanism by which it causes a particular toxic outcome, and the risk assessment decisions effected can in turn range from how to define equivalent exposures across species to whether a particular animal outcome is relevant to a human health assessment. A concept that has proven useful in support of these considerations is the "mode of action," a term coined by the USEPA in their new guidelines for carcinogen risk assessment. This paper describes the increasing use of mode-of-action considerations in risk assessment, beginning with early examples involving quantitative dosimetry on the one hand, and qualitative relevance on the other, which foreshadowed the current interest in mode of action. It then describes more recent developments regarding the use of the mode-of-action concept for the selection of a low-dose extrapolation approach, for harmonization of cancer and noncancer risk assessment approaches, and for cross-chemical evaluations. Finally, examples of recent controversies associated with the use of mode-of-action information in risk assessment are provided to demonstrate the challenges that must be overcome to assure the continued viability of the mode-of-action approach. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:3 / 14
页数:12
相关论文
共 61 条
[1]   Is ingested inorganic arsenic a ''Threshold'' Carcinogen? [J].
Abernathy, CO ;
Chappell, WR ;
Meek, ME ;
Gibb, H ;
Guo, HR .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1996, 29 (02) :168-175
[2]  
*ACGIH, 2002, DOC THRESH LIM VAL B
[3]   The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene [J].
Albertini, R ;
Clewell, H ;
Himmelstein, MW ;
Morinello, E ;
Olin, S ;
Preston, J ;
Scarano, L ;
Smith, MT ;
Swenberg, J ;
Tice, R ;
Travis, C .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2003, 37 (01) :105-132
[4]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[5]  
ANDERSEN ME, 1999, ARSENIC EXPOSURE HLT
[6]  
[Anonymous], 1999, Arsenic in drinking water
[7]  
[Anonymous], [No title captured]
[8]   Evaluating noncancer effects of trichloroethylene: Dosimetry, mode of action, and risk assessment [J].
Barton, HA ;
Clewell, HJ .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :323-334
[9]   Harmonization of cancer and noncancer risk assessment: Proceedings of a consensus-building workshop [J].
Bogdanffy, MS ;
Daston, G ;
Faustman, EM ;
Kimmel, CA ;
Kimmel, GL ;
Seed, J ;
Vu, V .
TOXICOLOGICAL SCIENCES, 2001, 61 (01) :18-31
[10]   Mode-of-action-based dosimeters for interspecies extrapolation of vinyl acetate inhalation risk [J].
Bogdanffy, MS ;
Plowchalk, DR ;
Sarangapani, R ;
Starr, TB ;
Andersen, ME .
INHALATION TOXICOLOGY, 2001, 13 (05) :377-396